JP2009524428A - スタヒロコッカス・アウレウスｏｒｆ０６５７ｎを標的とする抗原結合タンパク質 - Google Patents

スタヒロコッカス・アウレウスｏｒｆ０６５７ｎを標的とする抗原結合タンパク質 Download PDF

Info

Publication number
JP2009524428A
JP2009524428A JP2008552351A JP2008552351A JP2009524428A JP 2009524428 A JP2009524428 A JP 2009524428A JP 2008552351 A JP2008552351 A JP 2008552351A JP 2008552351 A JP2008552351 A JP 2008552351A JP 2009524428 A JP2009524428 A JP 2009524428A
Authority
JP
Japan
Prior art keywords
seq
mab
amino acids
region
binding protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008552351A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009524428A5 (enExample
Inventor
ブラウン，マーサ・ジエイ
アンダーソン，アンナリーザ・エス
コープ，レスリー・デイー
ヤンセン，カトリーン・ウテ
マクニーリー，テツシー
ハーベイ，バレット
デユール，エルベルハルト
アーンスト，ロビン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JP2009524428A publication Critical patent/JP2009524428A/ja
Publication of JP2009524428A5 publication Critical patent/JP2009524428A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/72—Increased effector function due to an Fc-modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2008552351A 2006-01-27 2007-01-23 スタヒロコッカス・アウレウスｏｒｆ０６５７ｎを標的とする抗原結合タンパク質 Withdrawn JP2009524428A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76302306P 2006-01-27 2006-01-27
PCT/US2007/001687 WO2007089470A2 (en) 2006-01-27 2007-01-23 Antigen-binding proteins targeting s. aureus orf0657n

Publications (2)

Publication Number Publication Date
JP2009524428A true JP2009524428A (ja) 2009-07-02
JP2009524428A5 JP2009524428A5 (enExample) 2010-03-11

Family

ID=38327867

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008552351A Withdrawn JP2009524428A (ja) 2006-01-27 2007-01-23 スタヒロコッカス・アウレウスｏｒｆ０６５７ｎを標的とする抗原結合タンパク質

Country Status (7)

Country Link
US (1) US20110091480A1 (enExample)
EP (1) EP1982185A4 (enExample)
JP (1) JP2009524428A (enExample)
CN (1) CN101375161A (enExample)
AU (1) AU2007210170A1 (enExample)
CA (1) CA2637152A1 (enExample)
WO (1) WO2007089470A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100166772A1 (en) * 2007-05-31 2010-07-01 Anderson Annaliesa S ANTIGEN-BINDING PROTEINS TARGETING S. AUREUS ORF0657n
US9181329B2 (en) 2007-08-31 2015-11-10 The University Of Chicago Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
CA2697538C (en) 2007-08-31 2019-02-12 University Of Chicago Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
US8758765B2 (en) 2008-07-29 2014-06-24 The University Of Chicago Compositions and methods related to Staphylococcal bacterium proteins
SMT202000246T1 (it) 2009-04-03 2020-07-08 Univ Chicago Composizioni e metodi relativi a varianti della proteina a (spa)
BR112013000097B1 (pt) 2010-07-02 2022-02-01 The University Of Chicago Polipeptídeo imunogênico isolado, composição imunogênica e seu uso
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6916605B1 (en) * 1990-07-10 2005-07-12 Medical Research Council Methods for producing members of specific binding pairs
BR0207068A (pt) * 2001-01-26 2004-12-21 Inhibitex Inc Anticorpo monoclonal para a protéina clfa, anti-soro isolado, anticorpo isolado e anticorpo humanizado contendo o referido anticorpo, kit diagnóstico compreendendo o referido anticorpo, método para diagnóstico de uma infecção por s.aureus, composição farmacêutica para o tratamento ou prevenção da referida infecção, método para indução de de uma resposta imunológica, método para identificação de anticorpos monoclonais para a protéina clfa e fragmento ativo isolado a partir do domìnio a da protéina clfa do s.aureus
US20070275460A1 (en) * 2003-03-03 2007-11-29 Xencor.Inc. Fc Variants With Optimized Fc Receptor Binding Properties
NZ544542A (en) * 2003-07-24 2009-01-31 Merck & Co Inc Polypeptides for inducing a protective immune response against staphylococcus aureus
US20060188515A1 (en) * 2003-07-24 2006-08-24 Anderson Annaliesa S Polypeptides for inducing a protective immune response against staphylococcus aureus
ES2589927T3 (es) * 2005-01-21 2016-11-17 Merck Sharp & Dohme Corp. Polipéptidos para inducir una respuesta inmunitaria protectora contra Staphylococcus aureus
WO2008140632A2 (en) * 2007-01-24 2008-11-20 Merck & Co., Inc. Polypeptides for inducing a protective immune response against staphylococcus epidermidis
WO2008115415A2 (en) * 2007-03-19 2008-09-25 Merck & Co., Inc Polypeptides for inducing a protective immune response against staphylococcus epidermidis
US20100166772A1 (en) * 2007-05-31 2010-07-01 Anderson Annaliesa S ANTIGEN-BINDING PROTEINS TARGETING S. AUREUS ORF0657n

Also Published As

Publication number Publication date
WO2007089470A3 (en) 2008-01-24
WO2007089470A2 (en) 2007-08-09
AU2007210170A1 (en) 2007-08-09
EP1982185A2 (en) 2008-10-22
WO2007089470A9 (en) 2007-11-01
EP1982185A4 (en) 2010-04-28
CA2637152A1 (en) 2007-08-09
CN101375161A (zh) 2009-02-25
US20110091480A1 (en) 2011-04-21

Similar Documents

Publication Publication Date Title
CN101679516B (zh) 靶向金黄色葡萄球菌ORF0657n的抗原结合蛋白
US8653242B2 (en) Therapeutic antibodies against flagellated Pseudomonas aeruginosa
US9914767B2 (en) Cross-reactive Staphylococcus aureus antibody
KR102531577B1 (ko) Pcsk9 항체, 및 약제학적 조성물 및 이의 용도
TR201808486T4 (tr) Bradikinin B1 reseptör ligandlarına karşı antikorlar.
JP2009524428A (ja) スタヒロコッカス・アウレウスｏｒｆ０６５７ｎを標的とする抗原結合タンパク質
JP7610515B2 (ja) ヒト化抗Ｎ短縮型アミロイドβモノクローナル抗体
JP2024522670A (ja) 呼吸器合胞体ウイルスに対する抗体及びその使用
US20240059764A1 (en) ANTIGEN-BINDING PROTEIN TARGETING STAPHYLOCOCCUS AUREUS a-HEMOLYSIS AND APPLICATION THEREOF
CN113416249B (zh) 针对破伤风毒素的组合物
CN114957460A (zh) 交叉中和金黄色葡萄球菌毒素的抗原结合蛋白及其用途
RU2815280C1 (ru) Антитело против столбнячного токсина и его применение
US20240174736A1 (en) Antigen-binding protein targeting pneumolysin and use thereof
TW202506731A (zh) 治療多重抗藥性細菌感染之方法
OA21922A (en) Antigen-binding protein targeting streptococcus pneumoniae hemolysin protein and use thereof.
CN119350502A (zh) 靶向fap的抗原结合蛋白及其应用
KR20220013854A (ko) 탄저균 보호항원에 특이적인 인간화 항체 및 이의 제조방법
TW202136308A (zh) 抗ｃｓｆ１ｒ分子及其用途
HK1243095B (zh) 一种抗白介素17a 的抗体、其制备方法和应用
HK1243095A1 (en) An anti-il-17a antibody, the preparation method and application thereof
HK1243095A (en) An anti-il-17a antibody, the preparation method and application thereof
NZ618266B2 (en) Anti-pseudomonas psl binding molecules and uses thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091207

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100120

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100120

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20111208